RecruitingNCT01221168
Epidemiologic and Genetic Study on Familial Prostate Cancer
ProGene: Etude Genetique et Epidemiologique du Cancer de la Prostate Familial
Sponsor
Centre de Recherche sur les Pathologies Prostatiques
Enrollment
10,000 participants
Start Date
Oct 1, 1996
Study Type
OBSERVATIONAL
Conditions
Summary
The aims of the study are: * to identify genetic and molecular factors (rare mutations, polymorphisms) involved in the natural history of prostate cancers and their response to treatment, * to evaluate and deduce their medical applications for screening and therapeutic management of these tumors.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- patient with a histological confirmed prostate cancer
- member of a hereditary prostate cancer family
- healthy control men without prostate cancer
Exclusion Criteria2
- Absence of signed informed consent
- refusal to participate in the study
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01221168
Related Trials
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
NCT057519412 locations